Board of Directors

Board of Directors


Providing vision and guidance to Gateway's mission is a robust group of individuals who have achieved success in their own fields. From banking to research to hospital management to foundations, the Board of Directors help Gateway set strategic priorities that are aligned with a diverse set of patient interests and needs.


Gateway Board of Directors

Richard J Stephenson - Chairman
Chairman of the Board, Cancer Treatment Centers of America

Harlan Teller - Vice Chairman
Interim V.P., Marketing & Communications, Northern Illinois University

Janice Anderson - Treasurer
Shareholder, Polsinelli

Rhonda Kokot - Secretary
Managing Partner, Simple Truth

Virginia Aherin - Director
Client Director, The Forum Corporation

Tony Festa - Director
Managing Principal & COO, Fund Evaluation Group, LLC

Susan Fleming - Director
Vice President of Marketing, Catamaran

Dan Garms - Director
The Garms Group

Heather Kane - Director
Senior Vice President, Exchange Strategy, UnitedHealthcare

Jennifer Stephenson Keller - Director
Director, Stephenson Family Foundation/Celebrate Life Foundation

Eva Kmiecic - Director
Vice President, LGT Executive Performance, Inc.

Margaret LaManna, MD - Director
President, International Healthcare Group, Inc.

Bruce Lubin - Director
President, Illinois Commercial & Specialty Banking, The PrivateBank

Michael T. Mullins - Director
Partner, Winston & Strawn, LLP

Deniz Razon - Director
Sr. Global Marketing Director, Oncology Strategy & Growth, Baxter BioScience

Edwin Roberson - Director
Chief Executive Officer, Christ Community Health Services

J. Terry Simmons - Director
V.P. of Global Purchasing & Supplier Management, AbbVie, Inc.

Mary Lou Smith - Director
Co-Founder, Research Advocacy Network

Stacie J. Stephenson - Director
Chairman, Functional Medicine, Cancer Treatment Centers of America

Christopher Surdenik - Director
Chief Executive Officer, Call One

Teresa Hall Bartels - Ex-Officio
President, Gateway for Cancer Research

Terry Sharrer - Ex-Officio Scientific Liaison
Principal, iMed R&D

99 cents of every dollar received directly funds cancer clinical trials


Current Gateway-funded clinical trials


Clinical trials funded at leading institutions worldwide


Funds one patient for one day at a Gateway-funded clinical trial


Mission Partners